ANI-7
ANI-7 is an activator of aryl hydrocarbon receptor (AhR) pathway. ANI-7 inhibits the growth of multiple cancer cells, and potently and selectively inhibits the growth of MCF-7 breast cancer cells with a GI50 of 0.56 μM. ANI-7 induces CYP1-metabolizing mono-oxygenases by activating AhR pathway, and also induces DNA damage, checkpoint Kinase 2 (Chk2) activation, S-phase cell cycle arrest, and cell death in sensitive breast cancer cell lines[1][2][3].
Product Specifications
CAS Number
931417-26-4
Product Name Alternative
Prodigiosine (hydrochloride)
UNSPSC
12352005
Target
Aryl Hydrocarbon Receptor; Checkpoint Kinase (Chk)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Immunology/Inflammation
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ani-7.html
Concentration
10mM
Purity
99.01
Solubility
DMSO : 20.83 mg/mL (ultrasonic)
Smiles
ClC1=CC(/C(C#N)=C/C2=CC=CN2)=CC=C1Cl
Molecular Formula
C13H8Cl2N2
Molecular Weight
263.12
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Chk2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Nostoc punctiforme Apocytochrome f (petA)
